{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:00:05Z","timestamp":1783065605528,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jad.2020.02.010","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T11:32:08Z","timestamp":1580729528000},"page":"578-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pregnancy exposure to venlafaxine\u2014Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes"],"prefix":"10.1016","volume":"266","author":[{"given":"Michael","family":"Paulzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.02.010_bib0001","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.11622\/smedj.2014061","article-title":"Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal?","volume":"55","author":"Ansary","year":"2014","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.jad.2020.02.010_bib0002","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bcp.13194","article-title":"SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn","volume":"83","author":"Berard","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2020.02.010_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00737-011-0251-1","article-title":"Untreated prenatal maternal depression and the potential risks to offspring: a review","volume":"15","author":"Davalos","year":"2012","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.jad.2020.02.010_bib0004","first-page":"1370","article-title":"Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy","volume":"147","author":"de Moor","year":"2003","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.jad.2020.02.010_bib0005","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study","volume":"158","author":"Einarson","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.2006-2133","article-title":"Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates","volume":"119","author":"Ferreira","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2020.02.010_bib0007","doi-asserted-by":"crossref","first-page":"h1798","DOI":"10.1136\/bmj.h1798","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design","volume":"350","author":"Furu","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.02.010_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(24)39087-1","article-title":"Placental transporters relevant to drug distribution across the maternal-fetal interface","volume":"294","author":"Ganapathy","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2020.02.010_bib0009","first-page":"154","article-title":"Untreated depression during pregnancy: Short- and long-term effects in offspring","volume":"342","author":"Gentile","year":"2017","journal-title":"A Syst. Rev. Neurosci."},{"key":"10.1016\/j.jad.2020.02.010_bib0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0037-1600991","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0011","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejpn.2016.11.003","article-title":"Neonatal venlafaxine discontinuation syndrome: A mini-review","volume":"21","author":"Holland","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jad.2020.02.010_bib0012","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0006-3223(00)00958-6","article-title":"Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women","volume":"48","author":"Hostetter","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2020.02.010_bib0014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"Iqbal","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.jad.2020.02.010_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.reprotox.2005.03.011","article-title":"The contribution of new findings and ideas to the old principles of teratology","volume":"20","author":"Jelinek","year":"2005","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jad.2020.02.010_bib0016","first-page":"B4916","article-title":"Exposure to antidepressants during pregnancy\u2013prevalences and outcomes","volume":"61","author":"Jimenez-Solem","year":"2014","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.jad.2020.02.010_bib0017","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"Kallen","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jad.2020.02.010_bib0018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(16)00003-1","article-title":"Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry","volume":"3","author":"Khalifeh","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0019","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.forsciint.2007.04.216","article-title":"Neonatal death following clozapine self-poisoning in late pregnancy: an unusual case report","volume":"171","author":"Klys","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jad.2020.02.010_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bcpt.12497","article-title":"First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review","volume":"118","author":"Lassen","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2020.02.010_bib0021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.163.1.145","article-title":"Antidepressants in amniotic fluid: another route of fetal exposure","volume":"163","author":"Loughhead","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0022","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s10995-016-2038-5","article-title":"Use of antidepressants during pregnancy?: What to consider when weighing treatment with antidepressants against untreated depression","volume":"20","author":"Muzik","year":"2016","journal-title":"Matern. Child Health J."},{"key":"10.1016\/j.jad.2020.02.010_bib0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/08039488.2011.650198","article-title":"Pharmacological treatment of unipolar depression during pregnancy and breast-feeding\u2013a clinical overview","volume":"66","author":"Nielsen","year":"2012","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0024","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","article-title":"Antidepressant use and risk for preeclampsia","volume":"24","author":"Palmsten","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.jad.2020.02.010_bib0026","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2017.09.043","article-title":"Pregnancy exposure to quetiapine - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes","volume":"195","author":"Paulzen","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2020.02.010_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","article-title":"Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"212","author":"Paulzen","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.02.010_bib0028","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pnpbp.2017.06.030","article-title":"Pregnancy exposure to citalopram - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"79","author":"Paulzen","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0029","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/JCP.13m08921","article-title":"Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid","volume":"76","author":"Paulzen","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/JCP.0000000000000308","article-title":"Suicide attempt during late pregnancy with quetiapine: nonfatal outcome despite severe intoxication","volume":"35","author":"Paulzen","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.02.010_bib0031","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000088","article-title":"Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood","volume":"30","author":"Paulzen","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.02.010_bib0032","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40262-018-0713-y","article-title":"Comprehensive Measurements of Intrauterine and Postnatal Exposure to Lamotrigine","volume":"58","author":"Paulzen","year":"2019","journal-title":"Clin. Pharmacokinetics"},{"key":"10.1016\/j.jad.2020.02.010_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/JCP.0b013e318192e4c1","article-title":"Comparison of the Pharmacokinetics of Venlafaxine Extended Release and Desvenlafaxine in Extensive and Poor Cytochrome P450 2D6 Metabolizers","volume":"29","author":"Preskorn","year":"2009","journal-title":"J. Clin. Psychopharm."},{"key":"10.1016\/j.jad.2020.02.010_bib0034","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1124\/dmd.110.033571","article-title":"The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies","volume":"38","author":"Prouillac","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jad.2020.02.010_bib0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S1461145704004286","article-title":"A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate","volume":"7","author":"Rampono","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.02.010_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0037","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0163-7258(99)00046-7","article-title":"Fetal hepatic drug elimination","volume":"84","author":"Ring","year":"1999","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.jad.2020.02.010_bib0038","article-title":"Antidepressants in breast milk; comparative analysis of excretion ratios","author":"Schoretsanitis","year":"2018","journal-title":"Arch. Womens Ment. Health."},{"key":"10.1016\/j.jad.2020.02.010_bib0039","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4088\/JCP.10m06461","article-title":"Mother-infant antidepressant concentrations, maternal depression, and perinatal events","volume":"72","author":"Sit","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.02.010_bib0040","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04332.x","article-title":"Prescribing without evidence - pregnancy","volume":"74","author":"Thomas","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2020.02.010_bib0041","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.jp.7211290","article-title":"Amniotic fluid: not just fetal urine anymore","volume":"25","author":"Underwood","year":"2005","journal-title":"J. Perinatol."},{"key":"10.1016\/j.jad.2020.02.010_bib0042","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/OGX.0000000000000369","article-title":"Psychopharmacotherapy in Pregnancy and Breastfeeding","volume":"71","author":"Vitale","year":"2016","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.jad.2020.02.010_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181082","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition","volume":"12","author":"Westin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2020.02.010_bib0044","unstructured":"Wyeth, Medication guide, approved by the F.D.A(https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/020699s054,057lbl.pdf), accessed (01\/12\/2020)."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719317628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719317628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:42:27Z","timestamp":1759023747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719317628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"alternative-id":["S0165032719317628"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.02.010","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy exposure to venlafaxine\u2014Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}